Opinion on Ibrutinib on 1st Line CLL

Opinion on Ibrutinib on 1st Line CLL

obr

8 months
198 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Paul M. Barr MD Associate Professor of Medicine at Wilmot Cancer Institute provides his opinion on ibrutinib in 1st line chronic lymphocytic leukemia (CLL).
Up Next Autoplay